KEMTA masterclass: Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
-
Masterclass
Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
By: Sabine Grimm/Bram Ramaekers
Language: English
The masterclasses will take place via Teams of Zoom. You can register by sending an e-mail to: Irene.vrancken@mumc.nl.
KEMTA (Clinical Epidemiology & Medical Technology Assessment) of MUMC+ regularly organises masterclasses for employees interested in research methods. The masterclasses give short insights into a variety of topics, from the basics of setting up research to statistics and hot topics such as early HTA.
Also read
-
PhD defence Louise David
" The Effort of Change: Understanding and Supporting Students’ Sustainable Use of Effective Learning Strategies"PhD defence18 May -
PhD defence Jayendra Sharma
" Universal health coverage in Bhutan: an empirical enquiry"PhD defence18 May -
PhD defence Sunita Mohan
" Empowering Community and Allied Health Workers for Diabetic Retinopathy Screening in Urban Slums: An Investigation into Competencies, Models, and Policy Implications"19 May